IO BIOTECH INC. - COMMON STOCK
N/A
31-December-69 18:00:00
15 minutes delayed
Stocks
N/A
Today's range
N/A - N/A
ISIN
N/A
Source
NASDAQ
-
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
14 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
01 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
IO Biotech to Present at the Jefferies Healthcare Conference
30 May 2023 15:35:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 First-Quarter Results
11 May 2023 15:05:01 By Nasdaq GlobeNewswire
-
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 Mar 2023 15:11:47 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in March 2023 Investor Conferences
22 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of Devin Smith as General Counsel
23 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
IO Biotech Provides Business Update
09 Jan 2023 06:05:46 By Nasdaq GlobeNewswire
-
IO Biotech Announces Third Quarter Results for 2022
09 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies London Healthcare Conference
31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of New Chief Financial Officer
13 Oct 2022 15:05:00 By Nasdaq GlobeNewswire
-
05 Oct 2022 07:05:00 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Second Quarter Results for 2022
11 Aug 2022 16:00:18 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in the 2022 BIO International Convention
06 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
26 May 2022 16:00:00 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies Healthcare Conference
23 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
18 May 2022 06:00:00 By Nasdaq GlobeNewswire